S
Srivalleesha Mallidi
Researcher at Tufts University
Publications - 94
Citations - 3545
Srivalleesha Mallidi is an academic researcher from Tufts University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 21, co-authored 77 publications receiving 2983 citations. Previous affiliations of Srivalleesha Mallidi include University of Texas System & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance
TL;DR: The role of photoacoustics and photoacoustic-augmented imaging techniques in comprehensive cancer detection, diagnosis and treatment guidance is examined.
Journal ArticleDOI
Development and Applications of Photo-triggered Theranostic Agents
Prakash Rai,Srivalleesha Mallidi,Xiang Zheng,Ramtin Rahmanzadeh,Youssef Mir,Stefan A. Elrington,Ahmat Khurshid,Ahmat Khurshid,Tayyaba Hasan,Tayyaba Hasan +9 more
TL;DR: Recent developments in the use of light-triggered theranostic agents for simultaneous imaging and photoactivation of therapeutic agents for several diseases are reviewed.
Journal ArticleDOI
Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer.
Srivalleesha Mallidi,Timothy Larson,Justina O. Tam,Pratixa P. Joshi,Andrei B. Karpiouk,Konstantin V Sokolov,Stanislav Emelianov +6 more
TL;DR: The results of this study suggest that highly selective and sensitive detection of cancer cells is possible using multiwavelength photoacoustic imaging and molecular specific gold nanoparticles.
Journal ArticleDOI
Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy.
Srivalleesha Mallidi,Sriram Anbil,Anne-Laure Bulin,Girgis Obaid,Megumi Ichikawa,Tayyaba Hasan +5 more
TL;DR: This review presents the recent advances, strategies and perspectives in PDT approaches, particularly in cancer treatment, that focus on increasing the 'damage zone' beyond the reach of light in the body.
Journal ArticleDOI
Molecular specific optoacoustic imaging with plasmonic nanoparticles.
TL;DR: The results of this study demonstrate that the combination of anti-EGFR gold ioconjugates and optoacoustic imaging can allow highly sensitive and selective detection of human epithelial cancer cells.